What You Should Know:
– Brightside Health, a teletherapy provider for depression, anxiety, and other mood disorders, raises $33M in Series C funding led by S32.
– The funding round, which included participation from existing investors alongside new partners like Kennedy Lewis, Time BioVentures, and Anne Wojcicki’s Redwood Pacific, will fuel Brightside Health’s expansion plans.
– The funding comes on the heels of the company’s recent expansion into Medicaid and Medicare programs, along with the success of their award-winning Crisis Care program for individuals at risk of suicide.
Addressing a Growing Need
With one in five adults in the United States struggling with mental health conditions, Brightside Health is well-positioned to address this critical need. Brightside Health offers a range of teletherapy services, including their award-winning Crisis Care program for individuals with elevated suicide risk. Their evidence-based approach combines precision psychiatry, clinically proven therapy, and a specialized Crisis Care program to deliver comprehensive mental healthcare.
Availability
Brightside Health’s services are currently available in all 50 states for commercially insured and self-pay patients. Additionally, they offer programs for Medicaid and Medicare beneficiaries in select states. The company is actively expanding its partnerships with payers to reach even more individuals in need. The Series C funding empowers them to continue expanding access to high-quality mental healthcare across the country.